Ophthalmic composition for the treatment of uveitis
US12419933B2 · kind B2 · utility
0Cited by
89References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 5, 2020 |
| Grant date | Sep 23, 2025 |
| Priority date | — |
| Expiry date | Apr 4, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides pharmaceutical compositions comprising cyclosporine dissolved in a semifluorinated alkane for use in the treatment of uveitis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.